BMY
Price:
$57.76
Market Cap:
$117.15B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphi...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1972-06-01
Stock Exchange
NYSE
Ticker
BMY
According to Bristol-Myers Squibb Company’s latest financial reports and current stock price. The company's current ROE is -36.26%. This represents a change of 194.12% compared to the average of -12.33% of the last 4 quarters.
The mean historical ROE of Bristol-Myers Squibb Company over the last ten years is 14.63%. The current -36.26% ROE has changed -347.85% with respect to the historical average. Over the past ten years (40 quarters), BMY's ROE was at its highest in in the September 2018 quarter at 13.94%. The ROE was at its lowest in in the March 2024 quarter at -72.23%.
Average
14.63%
Median
16.48%
Minimum
-23.78%
Maximum
35.29%
Discovering the peaks and valleys of Bristol-Myers Squibb Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 311.50%
Maximum Annual ROE = 35.29%
Minimum Annual Increase = -456.83%
Minimum Annual ROE = -23.78%
Year | ROE | Change |
---|---|---|
2023 | 27.27% | 33.87% |
2022 | 20.37% | 4.69% |
2021 | 19.46% | -181.81% |
2020 | -23.78% | -456.83% |
2019 | 6.66% | -81.12% |
2018 | 35.29% | 311.50% |
2017 | 8.58% | -68.87% |
2016 | 27.55% | 142.03% |
2015 | 11.38% | -15.63% |
2014 | 13.49% | -20.22% |
The current ROE of Bristol-Myers Squibb Company (BMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
22.36%
5-year avg
10.00%
10-year avg
14.63%
Bristol-Myers Squibb Company’s ROE is less than AbbVie Inc. (65.72%), less than Merck & Co., Inc. (29.27%), less than Gilead Sciences, Inc. (0.65%), less than Johnson & Johnson (20.94%), less than Eli Lilly and Company (65.15%), less than Pfizer Inc. (4.72%), less than Amgen Inc. (68.49%), less than Biogen Inc. (10.38%),
Company | ROE | Market cap |
---|---|---|
65.72% | $317.73B | |
29.27% | $251.57B | |
0.65% | $117.09B | |
20.94% | $351.15B | |
65.15% | $755.34B | |
4.72% | $151.34B | |
68.49% | $142.17B | |
10.38% | $21.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bristol-Myers Squibb Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bristol-Myers Squibb Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bristol-Myers Squibb Company's ROE?
How is the ROE calculated for Bristol-Myers Squibb Company (BMY)?
What is the highest ROE for Bristol-Myers Squibb Company (BMY)?
What is the 3-year average ROE for Bristol-Myers Squibb Company (BMY)?
What is the 5-year average ROE for Bristol-Myers Squibb Company (BMY)?
How does the current ROE for Bristol-Myers Squibb Company (BMY) compare to its historical average?